{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T10:20:25Z","timestamp":1788344425609,"version":"build-2803163510"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Chem Res"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00044-026-03604-8","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T05:16:33Z","timestamp":1786943793000},"page":"1755-1773","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Enhancement of antitumor activity through structural optimization of 2-(Benzylamino)-thieno[2,3-d]pyrimidin-4(3H)-ones"],"prefix":"10.1007","volume":"35","author":[{"given":"Nazariy","family":"Pokhodylo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kostiantyn","family":"Levchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nataliya","family":"Finiuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuliia","family":"Kozak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olha","family":"Klyuchivska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rostyslav","family":"Stoika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"key":"3604_CR1","unstructured":"World Health Organization. Global Cancer Observatory: Cancer Today https:\/\/gco.iarc.who.int\/today."},{"key":"3604_CR2","doi-asserted-by":"publisher","first-page":"e2400363","DOI":"10.1200\/GO-24-00363","volume":"10","author":"I Huivaniuk","year":"2024","unstructured":"Huivaniuk I, Kopetskyi V, Ivanykovych T, Nikiforchin A, Kizub D, Antoniv M, Dzhemiliev A, Powell B, Yaniuta S, Kacharian A, Podolianko A. Building an effective international medical evacuation program for Ukrainian patients with cancer amid prolonged military conflict. JCO Glob Oncol. 2024;10:e2400363. https:\/\/doi.org\/10.1200\/GO-24-00363.","journal-title":"JCO Glob Oncol"},{"key":"3604_CR3","doi-asserted-by":"publisher","first-page":"e2400053","DOI":"10.1200\/GO.24.00053","volume":"10","author":"A Dzhemiliev","year":"2024","unstructured":"Dzhemiliev A, Kizub D, Wanis KN, Allar BG, Vus V, Malovanna A, Huivaniuk I, Kopetskyi V, Beznosenko A, Shabat G, Antoniv M. Factors affecting colorectal cancer screening in primary care physician practices in Ukraine. JCO Glob Oncol. 2024;10:e2400053. https:\/\/doi.org\/10.1200\/GO.24.00053.","journal-title":"JCO Glob Oncol"},{"key":"3604_CR4","doi-asserted-by":"publisher","first-page":"e2400046","DOI":"10.1200\/GO.24.00046","volume":"11","author":"A Oszer","year":"2025","unstructured":"Oszer A, Kliuchkivska K, Ko\u0142odrubiec J, Sopilnyak A, Salek M, W\u0142odarski MW, Dutkiewicz M, Nowicka Z, Krawczuk-Rybak M, Styczy\u0144ski J, Machnik K. Evacuating patients with pediatric cancer from Ukraine: Impact on medical care capacity in Poland. JCO Glob Oncol. 2025;11:e2400046. https:\/\/doi.org\/10.1200\/GO.24.00046.","journal-title":"JCO Glob Oncol"},{"key":"3604_CR5","doi-asserted-by":"publisher","first-page":"e2200123","DOI":"10.1200\/GO.22.00123","volume":"8","author":"C Caglevic","year":"2022","unstructured":"Caglevic C, Rolfo C, Gil-Bazo I, Cardona A, Sapunar J, Hirsch FR, Gandara DR, Morgan G, Novello S, Garassino MC, Mountzios G. The armed conflict and the impact on patients with cancer in Ukraine: Urgent considerations. JCO Glob Oncol. 2022;8:e2200123. https:\/\/doi.org\/10.1200\/GO.22.00123.","journal-title":"JCO Glob Oncol"},{"key":"3604_CR6","doi-asserted-by":"publisher","first-page":"1024046","DOI":"10.3389\/fphar.2022.1024046","volume":"13","author":"N Khanyk","year":"2022","unstructured":"Khanyk N, Hromovyk B, Levytska O, Agh T, Wettermark B, Kardas P. The impact of the war on maintenance of long-term therapies in Ukraine. Front Pharmacol. 2022;13:1024046. https:\/\/doi.org\/10.3389\/fphar.2022.1024046.","journal-title":"Front Pharmacol"},{"key":"3604_CR7","unstructured":"European Federation of Pharmaceutical Industries and Associations (EFPIA). The impact of the war in Ukraine on oncology patients: Overview and recommendations for European and Ukrainian health authorities and policymakers, IQVIA. ; 2023. Available online: https:\/\/efpia.eu\/media\/677308\/efpia-the-impact-of-the-war-in-ukraine-on-oncology-patients_final.pdf"},{"key":"3604_CR8","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.bmc.2019.02.044","volume":"27","author":"EM Ali","year":"2019","unstructured":"Ali EM, Abdel-Maksoud MS, Oh CH. Thieno[2,3-d]pyrimidine as a promising scaffold in medicinal chemistry: Recent advances. Bioorg Med Chem. 2019;27:1159\u201394. https:\/\/doi.org\/10.1016\/j.bmc.2019.02.044.","journal-title":"Bioorg Med Chem"},{"key":"3604_CR9","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s00044-023-03040-y","volume":"32","author":"MTM Sayed","year":"2023","unstructured":"Sayed MTM, Hassan RA, Halim PA, El-Ansary AK. Recent updates on thienopyrimidine derivatives as anticancer agents. Med Chem Res. 2023;32:659\u201381. https:\/\/doi.org\/10.1007\/s00044-023-03040-y.","journal-title":"Med Chem Res"},{"key":"3604_CR10","doi-asserted-by":"publisher","unstructured":"Mghwary AE, Hassan RA, Halim PA, Abdelhameid MK. Advances in structural identification of some thieno[2,3-d]pyrimidine scaffolds as antitumor molecules: Synthetic approaches and control programmed cancer cell death potential. Bioorg Chem. 2024;107985. https:\/\/doi.org\/10.1016\/j.bioorg.2024.107985.","DOI":"10.1016\/j.bioorg.2024.107985"},{"key":"3604_CR11","doi-asserted-by":"publisher","first-page":"4998","DOI":"10.1021\/jm200216q","volume":"54","author":"K Miwa","year":"2011","unstructured":"Miwa K, Hitaka T, Imada T, Sasaki S, Yoshimatsu M, Kusaka M, et al. Discovery of 1-{4-[1-(2,6-difluorobenzyl)-5-[(dimethylamino)methyl]-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl]phenyl}-3-methoxyurea (TAK-385) as a potent, orally active, non-peptide antagonist of the human gonadotropin-releasing hormone receptor. J Med Chem. 2011;54:4998\u20135012. https:\/\/doi.org\/10.1021\/jm200216q.","journal-title":"J Med Chem"},{"key":"3604_CR12","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ejphar.2013.12.001","volume":"723","author":"D Nakata","year":"2014","unstructured":"Nakata D, Masaki T, Tanaka A, Yoshimatsu M, Akinaga Y, Asada M, Sasada R, Takeyama M, Miwa K, Watanabe T, Kusaka M. Suppression of the hypothalamic\u2013pituitary\u2013gonadal axis by TAK-385 (relugolix), a novel, investigational, orally active, small molecule gonadotropin-releasing hormone antagonist: Studies in human GnRH receptor knock-in mice. Eur J Pharmacol. 2014;723:167\u201374. https:\/\/doi.org\/10.1016\/j.ejphar.2013.12.001.","journal-title":"Eur J Pharmacol"},{"key":"3604_CR13","doi-asserted-by":"publisher","first-page":"114679","DOI":"10.1016\/j.ejmech.2022.114679","volume":"242","author":"F Zou","year":"2022","unstructured":"Zou F, Wang Y, Yu D, Liu C, Lu J, Zhao M, Ma M, Wang W, Jiang W, Gao Y, Zhang R. Discovery of the thieno[2,3-d]pyrimidine-2,4-dione derivative 21a: A potent and orally bioavailable gonadotropin-releasing hormone receptor antagonist. Eur J Med Chem. 2022;242:114679. https:\/\/doi.org\/10.1016\/j.ejmech.2022.114679.","journal-title":"Eur J Med Chem"},{"key":"3604_CR14","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ejmech.2018.05.028","volume":"154","author":"C-R Yang","year":"2018","unstructured":"Yang C-R, Peng B, Cao S-L, Ren T-T, Jiang W, Wang F-C, Li Y-S, Wang G, Li Z, Xu S, et al. Synthesis, cytotoxic evaluation and target identification of thieno[2,3-d]pyrimidine derivatives with a dithiocarbamate side chain at C2 position. Eur J Med Chem. 2018;154:324\u201340. https:\/\/doi.org\/10.1016\/j.ejmech.2018.05.028.","journal-title":"Eur J Med Chem"},{"key":"3604_CR15","doi-asserted-by":"publisher","first-page":"463","DOI":"10.2174\/1570180814666170530093549","volume":"15","author":"J Yong","year":"2018","unstructured":"Yong J, Lu C, Wu X. Synthesis and preliminarily cytotoxicity to A549, HCT116 and MCF-7 cell lines of thieno[2,3-d]pyrimidine derivatives containing isoxazole moiety. Lett Drug Des Discov. 2018;15:463\u201374. https:\/\/doi.org\/10.2174\/1570180814666170530093549.","journal-title":"Lett Drug Des Discov"},{"key":"3604_CR16","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14756366.2021.2010729","volume":"37","author":"FM Elmenier","year":"2022","unstructured":"Elmenier FM, Lasheen DS, Abouzid KAM. Design, synthesis, and biological evaluation of new thieno[2,3-d]pyrimidine derivatives as targeted therapy for PI3K with molecular modelling study. J Enzym Inhib Med Chem. 2022;37:315\u201332. https:\/\/doi.org\/10.1080\/14756366.2021.2010729.","journal-title":"J Enzym Inhib Med Chem"},{"key":"3604_CR17","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/ardp.201400098","volume":"347","author":"XL Yang","year":"2014","unstructured":"Yang XL, Wang TC, Lin S, Fan HX. Irreversible inhibitors of the epidermal growth factor receptor: Thienopyrimidine core with \u03b1,\u03b2-unsaturated amide side chain. Arch Pharm. 2014;347:552\u20138. https:\/\/doi.org\/10.1002\/ardp.201400098.","journal-title":"Arch Pharm"},{"key":"3604_CR18","doi-asserted-by":"publisher","first-page":"111786","DOI":"10.1016\/j.ejmech.2019.111786","volume":"185","author":"M Toolabi","year":"2020","unstructured":"Toolabi M, Moghimi S, Bakhshaiesh TO, Salarinejad S, Aghcheli A, Hasanvand Z, Nazeri E, Khalaj A, Esmaeili R, Foroumadi A. 6-Cinnamoyl-4-arylaminothienopyrimidines as highly potent cytotoxic agents: Design, synthesis and structure\u2013activity relationship studies. Eur J Med Chem. 2020;185:111786. https:\/\/doi.org\/10.1016\/j.ejmech.2019.111786.","journal-title":"Eur J Med Chem"},{"key":"3604_CR19","doi-asserted-by":"publisher","first-page":"631","DOI":"10.3390\/biom9100631","volume":"9","author":"S Zhang","year":"2019","unstructured":"Zhang S, Liu F, Hou X, Cao J, Dai X, Yu J, Huang G. Synthesis of novel analogs of thieno[2,3-d]pyrimidin-4(3H)-ones as selective inhibitors of cancer cell growth. Biomolecules. 2019;9:631. https:\/\/doi.org\/10.3390\/biom9100631.","journal-title":"Biomolecules"},{"key":"3604_CR20","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.bioorg.2018.09.022","volume":"81","author":"MM Fouad","year":"2018","unstructured":"Fouad MM, El-Bendary ER, Suddek GM, Shehata IA, El-Kerdawy MM. Synthesis and in vitro antitumor evaluation of some new thiophenes and thieno[2,3-d]pyrimidine derivatives. Bioorg Chem. 2018;81:587\u201398. . https:\/\/doi.org\/10.1016\/j.bioorg.2018.09.022","journal-title":"Bioorg Chem"},{"key":"3604_CR21","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1016\/j.bmc.2019.04.022","volume":"27","author":"M Zhang","year":"2019","unstructured":"Zhang M, Jiang L, Tao J, Pan Z, He M, Su D, He G, Jiang Q. Design, synthesis and biological evaluation of 4-aniline-thieno[2,3-d]pyrimidine derivatives as MNK1 inhibitors against renal cell carcinoma and nasopharyngeal carcinoma. Bioorg Med Chem. 2019;27:2268\u201379. https:\/\/doi.org\/10.1016\/j.bmc.2019.04.022.","journal-title":"Bioorg Med Chem"},{"key":"3604_CR22","doi-asserted-by":"publisher","first-page":"747","DOI":"10.2174\/1871520618666180124121441","volume":"18","author":"EA Mina","year":"2018","unstructured":"Mina EA, Ehab MG, Afaf AE-M, Farag AE-T. Synthesis of novel thieno[2,3-d]pyrimidine derivatives and evaluation of their cytotoxicity and MNK1 inhibitory activity. Anti-Cancer Agents Med Chem. 2018;18:747\u201356. https:\/\/doi.org\/10.2174\/1871520618666180124121441.","journal-title":"Anti-Cancer Agents Med Chem"},{"key":"3604_CR23","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1124\/dmd.114.057513","volume":"42","author":"L Salphati","year":"2014","unstructured":"Salphati L, Shahidi-Latham S, Quiason C, Barck K, Nishimura M, Alicke B, Pang J, Carano RA, Olivero AG, Phillips HS. Distribution of the phosphatidylinositol 3-kinase inhibitors pictilisib (GDC-0941) and GNE-317 in U87 and GS2 intracranial glioblastoma models \u2013 Assessment by matrix-assisted laser desorption ionization imaging. Drug Metab Dispos. 2014;42:1110\u20136. https:\/\/doi.org\/10.1124\/dmd.114.057513.","journal-title":"Drug Metab Dispos"},{"key":"3604_CR24","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s40265-016-0606-z","volume":"76","author":"ES Kim","year":"2016","unstructured":"Kim ES, Olmutinib. First global approval. Drugs. 2016;76:1153\u20137. https:\/\/doi.org\/10.1007\/s40265-016-0606-z.","journal-title":"Drugs"},{"key":"3604_CR25","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1021\/co5001376","volume":"17","author":"NT Pokhodylo","year":"2015","unstructured":"Pokhodylo NT, Shyyka OY, Matiychuk VS, Obushak MD. New convenient strategy for annulation of pyrimidines to thiophenes or furans via the one-pot multistep cascade reaction of 1H-tetrazoles with aliphatic amines. ACS Comb Sci. 2015;17:399\u2013403. https:\/\/doi.org\/10.1021\/co5001376.","journal-title":"ACS Comb Sci"},{"key":"3604_CR26","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.tetlet.2018.02.016","volume":"59","author":"OY Shyyka","year":"2018","unstructured":"Shyyka OY, Pokhodylo NT, Slyvka YI, Goreshnik EA, Obushak MD. Understanding the tetrazole ring cleavage reaction with hydrazines: Structural determination and mechanistic insight. Tetrahedron Lett. 2018;59:1112\u20135. https:\/\/doi.org\/10.1016\/j.tetlet.2018.02.016.","journal-title":"Tetrahedron Lett"},{"key":"3604_CR27","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3390\/scipharm86030028","volume":"86","author":"O Shyyka","year":"2018","unstructured":"Shyyka O, Pokhodylo N, Finiuk N, Matiychuk V, Stoika R, Obushak M. Anticancer activity evaluation of new thieno[2,3-d]pyrimidin-4(3H)-ones and thieno[3,2-d]pyrimidin-4(3H)-one derivatives. Sci Pharm. 2018;86:28. https:\/\/doi.org\/10.3390\/scipharm86030028.","journal-title":"Sci Pharm"},{"key":"3604_CR28","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1039\/C8OB02812E","volume":"17","author":"PK Mykhailiuk","year":"2019","unstructured":"Mykhailiuk PK. Saturated bioisosteres of benzene: Where to go next? Org Biomol Chem. 2019;17:2839\u201349. https:\/\/doi.org\/10.1039\/C8OB02812E.","journal-title":"Org Biomol Chem"},{"key":"3604_CR29","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s10593-020-02732-2","volume":"56","author":"OY Shyyka","year":"2020","unstructured":"Shyyka OY, Pokhodylo NT, Palchykov VA, Finiuk NS, Stoika RS, Obushak MD. Cage-like amines in the green protocol of transannular thieno[2,3-d]pyrimidinone formation as promising anticancer agents. Chem Heterocycl Compd. 2020;56:793\u20139. https:\/\/doi.org\/10.1007\/s10593-020-02732-2.","journal-title":"Chem Heterocycl Compd"},{"key":"3604_CR30","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/cber.19660990116","volume":"99","author":"K Gewald","year":"1966","unstructured":"Gewald K, Schinke E, B\u00f6ttcher H. 2-Amino-thiophene aus methylenaktiven Nitrilen, Carbonylverbindungen und Schwefel. Chem Ber. 1966;99:94\u2013100.","journal-title":"Chem Ber"},{"key":"3604_CR31","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/prac.19660320104","volume":"32","author":"K Gewald","year":"1966","unstructured":"Gewald K. Reaktion von methylenaktiven Nitrilen mit Senf\u00f6len und Schwefel. J Prakt Chem. 1966;32:26\u201330.","journal-title":"J Prakt Chem"},{"key":"3604_CR32","doi-asserted-by":"publisher","first-page":"3263","DOI":"10.1021\/jm00095a024","volume":"35","author":"NP Peet","year":"1992","unstructured":"Peet NP, Lentz NL, Sunder S, Dudley MW, Ogden AML. Conformationally restrained, chiral (phenylisopropyl)amino-substituted pyrazolo[3,4-d]pyrimidines and purines with selectivity for adenosine A1 and A2 receptors. J Med Chem. 1992;35:3263\u20139.","journal-title":"J Med Chem"},{"key":"3604_CR33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","volume":"46","author":"CA Lipinski","year":"2001","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 2001;46:3\u201326. https:\/\/doi.org\/10.1016\/S0169-409X(00)00129-0.","journal-title":"Adv Drug Deliv Rev"},{"key":"3604_CR34","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1021\/cc9800071","volume":"1","author":"AK Ghose","year":"1999","unstructured":"Ghose AK, Viswanadhan VN, Wendoloski JJ. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. J Comb Chem. 1999;1:55\u201368. https:\/\/doi.org\/10.1021\/cc9800071.","journal-title":"J Comb Chem"},{"key":"3604_CR35","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1021\/jm020017n","volume":"45","author":"DF Veber","year":"2002","unstructured":"Veber DF, Johnson SR, Cheng HY, Smith BR, Ward KW, Kopple KD. Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem. 2002;45:2615\u201323. https:\/\/doi.org\/10.1021\/jm020017n.","journal-title":"J Med Chem"},{"key":"3604_CR36","doi-asserted-by":"publisher","first-page":"3867","DOI":"10.1021\/jm000292e","volume":"43","author":"WJ Egan","year":"2000","unstructured":"Egan WJ, Merz KM, Baldwin JJ. Prediction of drug absorption using multivariate statistics. J Med Chem. 2000;43:3867\u201377. https:\/\/doi.org\/10.1021\/jm000292e.","journal-title":"J Med Chem"},{"key":"3604_CR37","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1021\/jm015507e","volume":"44","author":"I Muegge","year":"2001","unstructured":"Muegge I, Heald SL, Brittelli D. Simple selection criteria for drug-like chemical matter. J Med Chem. 2001;44:1841\u20136. https:\/\/doi.org\/10.1021\/jm015507e.","journal-title":"J Med Chem"},{"key":"3604_CR38","doi-asserted-by":"publisher","first-page":"3714","DOI":"10.1021\/jm000942e","volume":"43","author":"P Ertl","year":"2000","unstructured":"Ertl P, Rohde B, Selzer P. Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J Med Chem. 2000;43:3714\u20137. https:\/\/doi.org\/10.1021\/jm000942e.","journal-title":"J Med Chem"},{"key":"3604_CR39","doi-asserted-by":"publisher","first-page":"3743","DOI":"10.1002\/(SICI)1521-3773(19991216)38:24","volume":"38","author":"SJ Teague","year":"1999","unstructured":"Teague SJ, Davis AM, Leeson PD, Oprea T. The design of leadlike combinatorial libraries. Angew Chem Int Ed. 1999;38:3743\u20138. https:\/\/doi.org\/10.1002\/(SICI)1521-3773(19991216)38:24.","journal-title":"Angew Chem Int Ed"},{"key":"3604_CR40","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/cmdc.201600182","volume":"11","author":"A Daina","year":"2016","unstructured":"Daina A, Zoete V. A boiled-egg to predict gastrointestinal absorption and brain penetration of small molecules. ChemMedChem. 2016;11:1117\u201321. https:\/\/doi.org\/10.1002\/cmdc.201600182.","journal-title":"ChemMedChem"},{"key":"3604_CR41","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1021\/jm5019093","volume":"58","author":"JL Dahlin","year":"2015","unstructured":"Dahlin JL, Nissink JWM, Strasser JM, Francis S, Higgins L, Zhou H, Zhang Z, Walters MA. PAINS in the assay: Chemical mechanisms of assay interference and promiscuous enzymatic inhibition observed during a sulfhydryl-scavenging HTS. J Med Chem. 2015;58:2091\u2013113. https:\/\/doi.org\/10.1021\/jm5019093.","journal-title":"J Med Chem"},{"key":"3604_CR42","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.2147\/DDDT.S207224","volume":"13","author":"H Zhang","year":"2019","unstructured":"Zhang H, Han D, Lv T, Liu K, Yang Y, Xu X, Chen Y. Novel peptide myristoly-CM4 induces selective cytotoxicity in leukemia K562\/MDR and Jurkat cells by necrosis and\/or apoptosis pathway. Drug Des Devel Ther. 2019;13:2153\u201367. https:\/\/doi.org\/10.2147\/DDDT.S207224.","journal-title":"Drug Des Devel Ther"},{"key":"3604_CR43","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3892\/or.2021.8087","volume":"46","author":"YH Liu","year":"2021","unstructured":"Liu YH, Zhu M, Lei PP, Pan XY, Ma WN. ND\u201309 inhibits chronic myeloid leukemia K562 cell growth by regulating BCR\u2013ABL signaling. Oncol Rep. 2021;46:136. https:\/\/doi.org\/10.3892\/or.2021.8087.","journal-title":"Oncol Rep"},{"key":"3604_CR44","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1038\/nprot.2006.339","volume":"1","author":"NAP Franken","year":"2006","unstructured":"Franken NAP, Rodermond HM, Stap J, Haveman J, van Bree C. Clonogenic assay of cells in vitro. Nat Protoc. 2006;1:2315\u20139. https:\/\/doi.org\/10.1038\/nprot.2006.339.","journal-title":"Nat Protoc"},{"key":"3604_CR45","doi-asserted-by":"publisher","first-page":"4361","DOI":"10.3390\/molecules29184361","volume":"29","author":"AC Hangan","year":"2024","unstructured":"Hangan AC, Oprean LS, Dican L, Procopciuc LM, Sevastre B, Lucaciu RL. Metal-based drug\u2013DNA interactions and analytical determination methods. Molecules. 2024;29:4361. https:\/\/doi.org\/10.3390\/molecules29184361.","journal-title":"Molecules"},{"issue":"4","key":"3604_CR46","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3390\/cells12040659","volume":"12","author":"M Kciuk","year":"2023","unstructured":"Kciuk M, Gieleci\u0144ska A, Mujwar S, Ko\u0142at D, Ka\u0142uzi\u0144ska-Ko\u0142at \u017b, Celik I, Kontek R. Doxorubicin - an Agent with Multiple Mechanisms of Anticancer Activity. Cells. 2023;12(4):659. https:\/\/doi.org\/10.3390\/cells12040659.","journal-title":"Cells"},{"key":"3604_CR47","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.3390\/molecules31071195","volume":"31","author":"K Giercuszkiewicz-Ha\u015bnik","year":"2026","unstructured":"Giercuszkiewicz-Ha\u015bnik K, Morak-M\u0142odawska B, Jele\u0144 M. Molecularly Targeted Therapies in Oncology: Mechanisms, Resistance, and Combination Strategies. Molecules. 2026;31:1195. https:\/\/doi.org\/10.3390\/molecules31071195.","journal-title":"Molecules"},{"key":"3604_CR48","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1080\/10717544.2019.1591544","volume":"26","author":"A Lucas","year":"2019","unstructured":"Lucas A, Lam D, Cabrales P. Doxorubicin-loaded red blood cells reduced cardiac toxicity and preserved anticancer activity. Drug Deliv. 2019;26:433\u201342. https:\/\/doi.org\/10.1080\/10717544.2019.1591544.","journal-title":"Drug Deliv"},{"key":"3604_CR49","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/CAD.0000000000000686","volume":"30","author":"N Finiuk","year":"2019","unstructured":"Finiuk N, Klyuchivska O, Ivasechko I, Hreniukh V, Ostapiuk Y, Shalai Y, Panchuk R, Matiychuk V, Obushak M, Stoika R, Babsky A. Pro-apoptotic effects of novel thiazole derivative towards human glioma cells. Anticancer Drugs. 2019;30:27\u201337.","journal-title":"Anticancer Drugs"},{"key":"3604_CR50","doi-asserted-by":"publisher","first-page":"4609","DOI":"10.3390\/molecules30234609","volume":"30","author":"E Potapskyi","year":"2025","unstructured":"Potapskyi E, Lazewski D, Myszkiewicz J, Korza\u0144ska G, Kuzminska J, Popenda \u0141, Korza\u0144ski A, Zgo\u0142a-Grze\u015bkowiak A, Gielara-Korza\u0144ska A, Chmaj-Wierzchowska K, Finiuk N, Kozak Y, Ivasechko I, Stoika R, Lesyk R, Wierzchowski M. Promising anticancer activity of novel hydroxyethyloxy and bromo derivatives of curcumin and its complexes with BF\u2082. Molecules. 2025;30:4609. https:\/\/doi.org\/10.3390\/molecules30234609.","journal-title":"Molecules"},{"key":"3604_CR51","doi-asserted-by":"publisher","DOI":"10.1787\/9789264071001-en","volume-title":"Test No. 423: Acute Oral toxicity - Acute Toxic Class Method, OECD Guidelines for the Testing of Chemicals, Section 4","author":"OECD","year":"2002","unstructured":"OECD. Test No. 423: Acute Oral toxicity - Acute Toxic Class Method, OECD Guidelines for the Testing of Chemicals, Sect.\u00a0 4. Paris: OECD Publishing; 2002. https:\/\/doi.org\/10.1787\/9789264071001-en."},{"key":"3604_CR52","doi-asserted-by":"publisher","DOI":"10.1787\/9789264070684-en","volume-title":"Test No. 407: Repeated Dose 28-day Oral Toxicity Study in Rodents, OECD Guidelines for the Testing of Chemicals, Section 4","author":"OECD","year":"2025","unstructured":"OECD. Test No. 407: Repeated Dose 28-day Oral Toxicity Study in Rodents, OECD Guidelines for the Testing of Chemicals, Sect.\u00a0 4. Paris: OECD Publishing; 2025. https:\/\/doi.org\/10.1787\/9789264070684-en."}],"container-title":["Medicinal Chemistry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00044-026-03604-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00044-026-03604-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00044-026-03604-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T10:04:17Z","timestamp":1788343457000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00044-026-03604-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":52,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["3604"],"URL":"https:\/\/doi.org\/10.1007\/s00044-026-03604-8","relation":{},"ISSN":["1054-2523","1554-8120"],"issn-type":[{"value":"1054-2523","type":"print"},{"value":"1554-8120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,17]]},"assertion":[{"value":"23 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were performed in compliance with the European Convention for the Protection of Vertebrate Animals Used for Experimental and Other Scientific Purposes and approved by the Bioethics Committee of the Institute of Cell Biology of the National Academy of Sciences of Ukraine (Protocol No. 2025-1, dated by February 5, 2025).","order":1,"name":"Ethics","label":"Ethical statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}